DSPE-PEG2000-Mal ammonium
Based on 4 publication(s) in Google Scholar
DSPE-PEG-Maleimide has DSPE phospholipid and maleimide to prepare nanostructured lipid carrier. DSPE-PEG-Maleimide extends blood circulation time and higher stability for encapsulated agents.
For research use only. We do not sell to patients.
- Purity: 99.90%
- CAS No.: 474922-22-0
- Formula: (C2H4O)nC51H92N1O13P.H3N
- Molecular Weight:2000(Average)
-
Storage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) DSPE-PEG2000-Mal ammonium
More
Customer Validation & Images
-
Bio/Physico-chemical Assay
Biological Activity
The immune liposomes constructed by DSPE-PEG-Maleimide can be used for the delivery of brain drugs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 474922-22-0
-
Appearance Solid
-
Molecular Weight 2000(Average)
-
Formula (C2H4O)nC51H92N1O13P.H3N
-
Color White to off-white
-
SMILES
O=C(NCCOP(O)(OC[C@@H](COC(CCCCCCCCCCCCCCCCC)=O)OC(CCCCCCCCCCCCCCCCC)=O)=O)OCCOCCNC(CCN1C(C=CC1=O)=O)=O.N.[n]
-
Synonyms
DSPE-PEG2000 Maleimide ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] ammonium
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (4)
-
Journal Impact Factor
-
Most Recent
-
DSPE-PEG2000-Mal ammonium purchased from MedChemExpress. Usage Cited in: Compos B Eng. 2023 Oct 15, 111047.
The verification of DSPE-PEG2000-MAL-Cys-SDSSD by MALDI-TOF was performed. For the construction of BT-LGG-EVs, 1 mol Cys-SDSSD and 1 mol DSPE-PEG2000-Mal ammonium were mixed and allowed to react for 24 h to develop bone-targeting peptide DSPE-PEG-Mal-Cys-SDSSD.
-
J Tissue Eng
Cell-free osteoarthritis treatment with dual-engineered chondrocyte-targeted extracellular vesicles derived from mechanical loading primed mesenchymal stem cells. [Abstract]2025 Feb 8:16:20417314241312563. PMID: 39926048 -
-
Solvent & Solubility
DMF : 50 mg/mL (Need ultrasonic)
Ethanol : 33.33 mg/mL (Need ultrasonic)
Purity & Documentation
-
Data Sheet (267 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
[1]. Huwyler J, et, al. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14164-9. [Content Brief]
[2]. Schnorenberg MR, et, al. Synthesis and Purification of Homogeneous Lipid-Based Peptide Nanocarriers by Overcoming Phospholipid Ester Hydrolysis. ACS Omega. 2018 Oct 31;3(10):14144-14150. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
DSPE-PEG2000-Mal ammonium Related Classifications
HY-144004 Related Classifications
Powered by Bioz